H. James Harwood
Papers
1
Total Citations
32
H-Index
1
About
H. James Harwood is a distinguished researcher whose work centers on metabolic disease therapeutics, particularly the pharmacological inhibition of microsomal triglyceride transfer protein (MTP). His major contributions lie in the discovery and development of MTP inhibitors as a powerful strategy for lowering low-density lipoprotein (LDL) cholesterol. By demonstrating that blocking MTP effectively halts the hepatic secretion of very low density lipoproteins (VLDL) and the intestinal secretion of chylomicrons, Harwood established a highly efficacious target for treating dyslipidemia. His landmark 2002 paper, which details the use of high-throughput screening and parallel synthesis to identify clinically active MTP inhibitors, has garnered 32 citations and remains a foundational reference in the field. This work not only advanced the mechanistic understanding of lipid metabolism but also paved the way for novel therapeutic interventions. Harwood’s research has had a lasting impact on cardiovascular drug discovery, offering a potent mechanism for lowering atherogenic lipoproteins and inspiring further exploration into MTP-targeted therapies for patients with severe hypercholesterolemia.
Research Focus
Key Achievements
Top Papers
- 1